Showing results (431-440 of 819) with videos related to
Sort By:
Pageof 82
Cancer Treatment Reviews|September 16, 2023
Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trialsGiovanni Maria Iannantuono, Elias Chandran, Charalampos S Floudas, et al.Journal of Cutaneous Pathology|June 12, 2014
Validation of the VE1 immunostain for the BRAF V600E mutation in melanomaMichelle V Pearlstein, Daniel C Zedek, David W Ollila, et al.Journal for Immunotherapy of Cancer|April 14, 2022
Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfaYo-Ting Tsai, Julius Strauss, Nicole J Toney, et al.Human Pathology|March 13, 1998
Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinomaM L Gulley, M P Burton, D C Allred, et al.Human Pathology|August 28, 2002
T-cell blast crisis of chronic myelogenous leukemia manifesting as a large mediastinal tumorCharles C Ye, Carolina Echeverri, Jeanne E Anderson, et al.Digestive Diseases and Sciences|March 14, 2012
Epstein-Barr virus infection is common in inflamed gastrointestinal mucosaJulie L Ryan, You-Jun Shen, Douglas R Morgan, et al.Frontiers in Public Health|April 6, 2026
Applying Photovoice to uncover fundamental causes of health inequality in local health contextsMarisa Booty, Madelyne Culbertson, Mason Taylor, et al.Nature Reviews. Urology|November 13, 2019
Radium-223 mechanism of action: implications for use in treatment combinationsMichael J Morris, Eva Corey, Theresa A Guise, et al.Human Vaccines & Immunotherapeutics|June 26, 2015
Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809)Douglas G McNeel, Yu-Hui Chen, James L Gulley, et al.Journal of Virology|October 29, 2005
Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell linesGregory K Hong, Pawan Kumar, Ling Wang, et al.Pageof 82